跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Aclav-625
Approved
STANDARD
Aclav-625
M.K. Pharma Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
78195a9c88c0ad7c
Company
M.K. Pharma Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
78195a9c88c0ad7c
Drug Approval Philippines Name
Aclav-625
Product Name
Aclav-625
Registration Number
DR-XY47501
Brand Name
Aclav-625
Generic Name
Co-amoxiclav
Dosage Form
Film-Coated Tablet
Dosage Strength
625 mg
Manufacturer
M.K. Pharma Pvt. Ltd.
Importer
Aglobal Care, Inc.
Distributor
Aglobal Care, Inc.
Issuance Date
29 October 2021
Expiry Date
29 October 2026
Pharmacologic Category
Antibacterial (Penicillin and Beta-lactamase inhibitor)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
78195a9c88c0ad7c
Type
Standard
Back to Philippines FDA Approvals
Aclav-625 - Philippines FDA Drug Approval Details